Uploaded November 2026 | Updated November 2026, 3 days ago
Health systems across Europe are evolving as digital tools, AI and new care models reshape how clinical research is conducted. At the same time, workforce shortages and rising demand are challenging the ability to scale trials; WHO Europe estimates a region-wide shortage of nearly 1m health workers by 2030. How can health systems design the workforce, workflows and technologies needed to support both high-quality care and broader participation in research? This panel explores how to build a more integrated, patient-centred clinical research ecosystem that works effectively across sites, communities and borders.
Moderator: Slavea Chankova, healthcare correspondent, The Economist
Noha Kassem, vice-president, trial capabilities, Eli Lilly and Company
Kamila Hawthorne, chair, National Academy of Social Prescribing
Martin Landray, chief executive, professor of medicine and epidemiology, Oxford Population Health
Health systems across Europe are evolving as digital tools, AI and new care models reshape how clinical research is conducted. At the same time, workforce shortages and rising demand are challenging the ability to scale trials; WHO Europe estimates a region-wide shortage of nearly 1m health workers by 2030. How can health systems design the workforce, workflows and technologies needed to support both high-quality care and broader participation in research? This panel explores how to build a more integrated, patient-centred clinical research ecosystem that works effectively across sites, communities and borders.
Moderator: Slavea Chankova, healthcare correspondent, The Economist
Noha Kassem, vice-president, trial capabilities, Eli Lilly and Company
Kamila Hawthorne, chair, National Academy of Social Prescribing
Martin Landray, chief executive, professor of medicine and epidemiology, Oxford Population Health










